Understanding Xylazine
This session focuses on the insights and perspectives of Poison Control Center clinicians in addressing opioid use disorder (OUD) care issues in our local region,…
This session focuses on the insights and perspectives of Poison Control Center clinicians in addressing opioid use disorder (OUD) care issues in our local region,…
This session focuses on the insights and perspectives of Poison Control Center clinicians in addressing opioid use disorder (OUD) care issues in our local region,…
Kevin Osterhoudt, MD, MSCE, FAAP, FACMT, is an attending physician in the Division of Emergency Medicine and the medical director of the Poison Control Center at…
It’s hard to call an opioid overdose an accident when it happens to a young child — at home and under supervision. Some fatal poisonings…
This session will review trends in substance use and overdose in Philadelphia, PA, and the United States. Treatment recommendations including harm reduction resources and benefits…
Buprenorphine is one of the gold standard medications utilized for treatment of opioid use disorder (OUD). One of the major barriers to buprenorphine maintenance is…
This session will explore evidence demonstrating how addiction can be considered a pediatric disease as well as treatment currently provided to adolescent patients with Opioid…
This session will explore the many ways in which opioid epidemic affects pediatric medicine, from toddler exploratory poisonings, to young patients’ parental loss, neonatal abstinence…
Notice: This lecture was delivered on October 12, 2020. Per our 3-year review policy, we’ve decided to maintain this lecture on CHOP OPEN. This content…